Table 3.
Results of the major Eastern series of HCC treated by MWA or RFA
| Author, year [reference] | Number of patients/nodules | Tumor size (cm)* | CAR | LTP | 1-Y DFS | 5-Y DFS | 1-Y OS | 5-Y OS |
|---|---|---|---|---|---|---|---|---|
| Zhang, 2013 [40] | RFA: 78/97 | RFA: 2.3; 0.8–5 | RFA: 83% | RFA: 12% | RFA: 70% | RFA: 34% | RFA: 91% | RFA: 41% |
| MWA: 77/105 | MWA: 2.2; 0.9–5 | MWA: 87% | MWA: 10% | MWA: 62% | MWA: 21% | MWA: 92% | MWA: 38% | |
| Ding, 2013 [41] | RFA: 85/98 | RFA: 2.38; 1–4.8 | RFA: 99% | RFA: 5% | RFA: 80% | RFA: 19% | RFA: 99% | RFA: 78% |
| MWA: 113/131 | MWA: 2.55; 0.8–5 | MWA: 98% | MWA: 10% | MWA: 75% | MWA: 16% | MWA: 98% | MWA: 78% | |
| Shiina, 2012 [39] | RFA: 1170/2982 | RFA: 2.54 ± 1.04** | RFA: 99% | RFA: 3% | RFA: 73% | RFA: 22% | RFA: 97% | RFA: 60% |
| Ohmoto, 2009 [42] | RFA: 34/37 | RFA: 1.6; 0.7–2 | n.a. | RFA: 9% | RFA: 63% | RFA: 26% | RFA: 100% | RFA: 70% |
| MWA: 49/56 | MWA: 1.7; 0.8–2 | MWA: 19% | MWA: 52% | MWA: 3% | MWA: 89% | MWA: 39% | ||
| Lu, 2005 [43] | RFA: 53/98 | RFA: 2.6; 1–6.1 | RFA: 93% | RFA: 21% | RFA: 37% | RFA: n.a. | RFA: 72% | RFA: 37% |
| MWA: 49/72 | MWA: 1.7; 0.9–7.2 | MWA: 95% | MWA: 12% | MWA: 46% | MWA: 13% | MWA: 82% | MWA: 24% | |
| Shibata, 2002 [44] | RFA: 36/48 | RFA: 2.3; 1–3.7 | RFA: 96% | RFA: 12% | n.a. | n.a. | n.a. | n.a. |
| MWA: 36/46 | MWA: 2.2; 0.9–3.4 | MWA: 89% | MWA: 24% |
CAR=complete ablation rate.
*
Values are the median and range;
**
Values are the mean and standard deviation.